Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Nucleoside. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114149475B reveals a novel two-step Azvudine synthesis avoiding phosphorus oxychloride, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel lithium salt condensation method for nucleoside-5'-phosphodiesters. Eliminates ion exchange resins and hazardous hydrogenation, offering safer, scalable manufacturing for API intermediates.
Patent CN107827890A reveals dynamic kinetic resolution for high-purity chiral purine acyclic nucleosides offering supply chain reliability and cost reduction.
Patent CN1193021A discloses a scalable method for synthesizing stavudine (d4T) from 5-methyluridine using zinc reductive elimination, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Patent CN113423714A details a novel sulfonylation route for 3'-O-amino-ribonucleotides, offering improved selectivity and scalability for nucleic acid manufacturing.
Patent CN102127135A reveals a mild, gold-catalyzed glycosylation method for pyrimidine and purine nucleosides, offering significant cost reduction in API manufacturing.
Patent CN111574523A reveals a novel one-step synthesis for 1'-substituted carbon nucleoside analogs, offering significant cost reduction and supply chain reliability for antiviral drug manufacturers.
Patent CN113248508A reveals a halogen-free synthesis of C-nucleosides, offering cost reduction and higher yields for antiviral API manufacturing.
Patent CN112480197B reveals a cost-effective route for cytosine nucleoside using cyanoacetaldehyde urea acetal, offering significant supply chain advantages.
Patent CN109553610A details a novel six-step synthesis for emtricitabine isomers offering high purity and scalable manufacturing processes for global supply chains.
Novel patent CN115109104B offers mild conditions and reduced purification steps for cordycepin, ensuring supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN108239128A reveals TMSOTf catalysis for high-purity beta-nucleosides. Enhances supply chain reliability and cost reduction in pharma manufacturing.
Novel 3-step synthesis of Cytosine Nucleoside from cyanoacetaldehyde urea acetal. High yield, cost-effective route for antiviral API manufacturing.
Patent CN103467552A reveals a metal-free route for 8-cyclohexyl-2-fluoro-vidarabine. Enhanced purity and scalable manufacturing for anti-leukemia drug development.
Patent CN112661802B reveals a scalable synthesis of 3'-methoxyguanosine, offering cost reduction in mRNA cap analog manufacturing and reliable supply chain solutions.
Patent CN1133641C details novel AZT prodrugs with enhanced antiviral activity. Offers scalable synthesis for pharmaceutical intermediates.
Patent CN102603652A reveals a mild three-step synthesis for 5-formylpyrimidine carbocyclic nucleosides, offering a reliable route for antiviral intermediate manufacturing.
Patent CN107501266A details a novel Pd-catalyzed asymmetric allylic amination route for high-purity nucleoside intermediates, offering significant supply chain and cost advantages.
Patent CN102010455B reveals a novel Decitabine synthesis avoiding isomer separation. High purity >99.85% via Barton-McCombie deoxygenation for cost-effective manufacturing.
Patent CN109761984B details a novel ruthenium-catalyzed asymmetric hydrogen transfer method for synthesizing chiral purine nucleosides with high enantioselectivity and mild conditions.